Modules

The online course consists of 10 modules with pre- and post-tests.

Each module also has a feedback survey - completing these is a great help to us so we can improve and learn for our future online courses.

Module overview
Module 1Clinical and economic importance of optimizing dose
Mark Ratain, The University of Chicago
Module 2Placing preclinical drug metabolism and pharmacokinetic data in context
Magnus Ingelman-Sundberg, Karolinska Institutet
Module 3Redefining the primary objective of phase 1 trials
Ruth Plummer, Newcastle University
Module 4Clinical endpoints useful for guiding early clinical development
Jaap Verweij, Erasmus Medical Centre
Module 5Pharmacometrics for the non-pharmacometrician
Lena Friberg, Uppsala University
Module 6Using genetic and pharmacokinetic data from early clinical trials to guide subsequent clinical development
Magnus Ingelman-Sundberg, Karolinska Institutet
Module 7Optimizing the use of pharmacodynamic biomarkers
Mark Ratain, The University of Chicago
Module 8Trial designs for the development of combinations of an investigational drug and a marketed drug
Jaap Verweij, Erasmus Medical Centre
Module 9Challenges for the development of immunotherapy drugs and combinations
Ruth Plummer, Newcastle University
Module 10Use of clinical trial simulation in oncology drug development
Lena Friberg, Uppsala University

 

FACULTY